Royal Bank of Canada’s Halozyme HALO Stock Holding History

Royal Bank of Canada’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-85,000	Closed	-$3.42M	–	7849
2021 Q4	$3.42M	Buy	+85,000	New	+$3.17M	﹤0.01%	2682
2020 Q4	–	Sell	-15,000	Closed	-$394K	–	7148
2020 Q3	$394K	Sell	15,000 -60,000	-80%	-$1.67M	﹤0.01%	4060
2020 Q2	$2.01M	Buy	75,000 +60,000	+400%	+$1.35M	﹤0.01%	2604
2020 Q1	$270K	Buy	+15,000	New	+$285K	﹤0.01%	4113
2018 Q3	–	Sell	-15,300	Closed	-$258K	–	6804
2018 Q2	$258K	Buy	+15,300	New	+$289K	﹤0.01%	4258
2015 Q3	–	Sell	-3,500	Closed	-$79K	–	6697
2015 Q2	$79K	Buy	+3,500	New	+$61.5K	﹤0.01%	4959
2014 Q4	–	Sell	-176,800	Closed	-$1.61M	–	6218
2014 Q3	$1.61M	Buy	176,800 +126,800	+254%	+$1.21M	﹤0.01%	2486
2014 Q2	$494K	Buy	50,000 +39,000	+355%	+$331K	﹤0.01%	3409
2014 Q1	$140K	Sell	11,000 -79,000	-88%	-$1.17M	﹤0.01%	4358
2013 Q4	$1.35M	Buy	90,000 +80,000	+800%	+$1.03M	﹤0.01%	2594
2013 Q3	$110K	Buy	+10,000	New	+$83.3K	﹤0.01%	4424

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's HALO Position: Q1 2026 in Review

Royal Bank of Canada increased its Halozyme (HALO) stake by 6.6% in Q1 2026, buying an estimated $2.88M and bringing the position to 658,290 shares worth $42.5M. The position accounts for 0.01% of the portfolio, ranked #1000.

Royal Bank of Canada first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.7M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Royal Bank of Canada held 658,290 shares of Halozyme worth $42.5M as of Q1 2026.
Royal Bank of Canada bought 40,885 Halozyme shares in Q1 2026, an estimated $2.88M.
Halozyme made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1000 holding.
Royal Bank of Canada first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Halozyme position peaked at $69.7M in Q3 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.